We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.49B
1-Year Est. Return 32.81%
This Fund
S&P 500
This Quarter Est. Return
+2.31%
1 Year Est. Return
+32.81%
3 Year Est. Return
+72.16%
5 Year Est. Return
+93.56%
10 Year Est. Return
+463.13%
AUM
$1.37B
AUM Growth
+$256M
Cap. Flow
+$243M
Cap. Flow %
17.72%
Top 10 Hldgs %
18.13%
Holding
125
New
1
Increased
114
Reduced
8
Closed
2

Sector Composition

Rank Sector Weight
1 Industrials 22.52%
2 Technology 17.87%
3 Financials 17.73%
4 Healthcare 11.81%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCF
26
DELISTED
TCF Financial Corporation Common Stock
TCF
$14.8M 1.07%
275,853
+64,691
+31% +$3.48M
AIN icon
27
Albany International
AIN
$1.71B
$14.5M 1.06%
236,505
+71,096
+43% +$4.28M
EFII
28
DELISTED
Electronics for Imaging
EFII
$14.5M 1.06%
490,982
+108,785
+28% +$3.64M
PBH icon
29
Prestige Consumer Healthcare
PBH
$2.22B
$14.2M 1.03%
319,686
+104,023
+48% +$4.74M
HASI icon
30
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.68B
$14.1M 1.02%
584,367
+65,101
+13% +$1.56M
MATW icon
31
Matthews International
MATW
$623M
$14M 1.02%
264,322
+58,146
+28% +$3.39M
BBT
32
Beacon Financial Corp
BBT
$2.61B
$13.8M 1.01%
377,936
+84,803
+29% +$3.23M
AIMC
33
DELISTED
Altra Industrial Motion Corp
AIMC
$13.7M 1%
272,478
+53,340
+24% +$2.55M
QDEL icon
34
QuidelOrtho
QDEL
$739M
$13.6M 0.99%
314,402
-5,958
-2% -$244K
AEIS icon
35
Advanced Energy
AEIS
$10.1B
$13.6M 0.99%
201,612
-19,585
-9% -$1.58M
NDAQ icon
36
Nasdaq
NDAQ
$49.6B
$13.6M 0.99%
530,016
+197,664
+59% +$4.99M
ROG icon
37
Rogers Corp
ROG
$2.3B
$13.6M 0.99%
83,812
-46,833
-36% -$7.06M
PACW
38
DELISTED
PacWest Bancorp
PACW
$13.5M 0.98%
267,371
+59,346
+29% +$2.83M
EVHC
39
DELISTED
Envision Healthcare Holdings Inc
EVHC
$13.2M 0.96%
381,061
+82,170
+27% +$2.87M
AEL
40
DELISTED
American Equity Investment Life Holding Company
AEL
$13M 0.94%
421,789
+95,113
+29% +$2.88M
PAY
41
DELISTED
Verifone Systems Inc
PAY
$12.7M 0.93%
717,156
+161,843
+29% +$3.01M
FFBC icon
42
First Financial Bancorp
FFBC
$3.38B
$12.3M 0.9%
468,083
+110,372
+31% +$2.99M
IWM icon
43
iShares Russell 2000 ETF
IWM
$76.5B
$12.3M 0.9%
80,839
+9,286
+13% +$1.39M
CCRN
44
DELISTED
Cross Country Healthcare
CCRN
$12.3M 0.9%
964,967
+202,767
+27% +$2.68M
MODV
45
DELISTED
ModivCare
MODV
$12.1M 0.88%
204,274
+22,752
+13% +$1.29M
NUS icon
46
Nu Skin
NUS
$223M
$12.1M 0.88%
177,631
+35,752
+25% +$2.31M
AZPN
47
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$12.1M 0.88%
182,554
+40,661
+29% +$2.69M
MRCY icon
48
Mercury Systems
MRCY
$5.25B
$12M 0.87%
232,754
+26,864
+13% +$1.38M
SLRC icon
49
SLR Investment Corp
SLRC
$656M
$11.9M 0.87%
591,253
+93,981
+19% +$2M
RES icon
50
RPC Inc
RES
$1.33B
$11.8M 0.86%
461,720
+102,298
+28% +$2.46M

Similar funds

Aristotle Capital Boston's Q4 2017 Portfolio in Review

As of Q4 2017, Aristotle Capital Boston held 125 positions worth $1.37B, up 23% from $1.12B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Aristotle Capital Boston deployed $243M of net new capital in Q4 2017, opening 1 new position and adding to 114 existing holdings. Its largest new stake was HMS Holdings Corp.: 291,021 shares worth $4.93M.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, down from 24% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Rogers Corp, an estimated $7.06M trimmed.

  • Aristotle Capital Boston's largest Q4 2017 buy was HMS Holdings Corp.: 291,021 shares worth $4.93M.
  • Aristotle Capital Boston added most to Acadia Healthcare in Q4 2017, an estimated $6.25M increase.
  • Aristotle Capital Boston's biggest Q4 2017 reduction was Rogers Corp, cutting an estimated $7.06M.
  • Aristotle Capital Boston fully exited Parexel International Corp in Q4 2017, selling an estimated $17M.
  • Aristotle Capital Boston's ten largest holdings make up 18% of its $1.37B portfolio in Q4 2017.
  • Aristotle Capital Boston opened 1 new position and closed 2 in Q4 2017.
  • Aristotle Capital Boston's portfolio value rose 23% quarter-over-quarter to $1.37B.

Based on Aristotle Capital Boston's 13F filing for Q4 2017, filed 14 Feb 2018.